55 related articles for article (PubMed ID: 38471014)
1. Synthesis of Sorafenib-Ruthenium Complexes, Investigation of Biological Activities and Applications in Drug Delivery Systems as an Anticancer Agent.
Zengin Kurt B; Öztürk Civelek D; Çakmak EB; Kolcuoğlu Y; Şenol H; Sağlık Özkan BN; Dag A; Benkli K
J Med Chem; 2024 Mar; 67(6):4463-4482. PubMed ID: 38471014
[TBL] [Abstract][Full Text] [Related]
2. 1118-20, an indazole diarylurea compound, inhibits hepatocellular carcinoma HepG2 proliferation and tumour angiogenesis involving Wnt/β-catenin pathway and receptor tyrosine kinases.
Lu YY; Wang JJ; Zhang XK; Li WB; Guo XL
J Pharm Pharmacol; 2015 Oct; 67(10):1393-405. PubMed ID: 26076716
[TBL] [Abstract][Full Text] [Related]
3. Fucoidan inhibits EGFR redistribution and potentiates sorafenib to overcome sorafenib-resistant hepatocellular carcinoma.
Luo J; Li L; Zhu Z; Chang B; Deng F; Wang D; Lu X; Zuo D; Chen Q; Zhou J
Biomed Pharmacother; 2022 Oct; 154():113602. PubMed ID: 36029544
[TBL] [Abstract][Full Text] [Related]
4. meta-Ureidophenoxy-1,2,3-triazole hybrid as a novel scaffold for promising HepG2 hepatocellular carcinoma inhibitors: Synthesis, biological evaluation and molecular docking studies.
Limpachayaporn P; Nuchpun S; Sirirak J; Charoensuksai P; Wongprayoon P; Chuaypen N; Tangkijvanich P; Suksamrarn A
Bioorg Med Chem; 2022 Nov; 74():117048. PubMed ID: 36270111
[TBL] [Abstract][Full Text] [Related]
5. Validation of VX2 as a Hepatocellular Carcinoma Model: Comparison of the Molecular Reaction of VX2 and HepG2 Tumor Cells to Sorafenib In Vitro.
Nass N; Streit S; Wybranski C; Jürgens J; Brauner J; Schulz N; Powerski M; Ricke J; Kalinski T; Dudeck O; Seidensticker M
Anticancer Res; 2017 Jan; 37(1):87-93. PubMed ID: 28011478
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of acquired-resistance hepatocellular carcinoma cell growth by combining sorafenib with phosphoinositide 3-kinase and rat sarcoma inhibitor.
Wu CH; Wu X; Zhang HW
J Surg Res; 2016 Dec; 206(2):371-379. PubMed ID: 27884331
[TBL] [Abstract][Full Text] [Related]
7. Novel complex compounds of nickel with 3-(1-phenyl-2,3-dimethyl-pyrazolone-5)azopentadione-2,4: synthesis, NBO analysis, reactivity descriptors and
Tahirli S; Aliyeva F; Şenol H; Demukhamedova S; Akverdieva G; Aliyeva I; Veysova S; Sadeghian N; Günay S; Erden Y; Taslimi P; Sujayev A; Chiragov F
J Biomol Struct Dyn; 2024 Jan; ():1-25. PubMed ID: 38294759
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Anticancer Activity of Novel Derivatives of α,β-Unsaturated Ketones Based on Oleanolic Acid: in Vitro and in Silico Studies against Prostate Cancer Cells.
Şenol H; Ghaffari-Moghaddam M; Bulut Ş; Akbaş F; Köse A; Topçu G
Chem Biodivers; 2023 Sep; 20(9):e202301089. PubMed ID: 37596247
[TBL] [Abstract][Full Text] [Related]
9. Screening assays for tyrosine kinase inhibitors: A review.
Gao J; Jian J; Jiang Z; Van Schepdael A
J Pharm Biomed Anal; 2023 Jan; 223():115166. PubMed ID: 36403346
[TBL] [Abstract][Full Text] [Related]
10. A Photoactivated Sorafenib-Ruthenium(II) Prodrug for Resistant Hepatocellular Carcinoma Therapy through Ferroptosis and Purine Metabolism Disruption.
Lai Y; Lu N; Luo S; Wang H; Zhang P
J Med Chem; 2022 Oct; 65(19):13041-13051. PubMed ID: 36134739
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of ursolic acid arylidene-hydrazide hybrid compounds and investigation of their cytotoxic and antimicrobial effects.
Şenol H; Şahin RB; Mercümek B; Kapucu HB; Hacıosmanoğlu E; Dinç HÖ; Yüksel Mayda P
Nat Prod Res; 2023; 37(15):2500-2507. PubMed ID: 35275500
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of cytotoxic and antioxidant potential of Dittrichia viscosa (L.) Greuter used in traditional medicine.
Sevgi E; Dag A; Kızılarslan-Hançer Ç; Atasoy S; Kurt BZ; Aksakal Ö
J Ethnopharmacol; 2021 Aug; 276():114211. PubMed ID: 34015367
[TBL] [Abstract][Full Text] [Related]
13. Polymeric Encapsulation of a Ru(II)-Based Photosensitizer for Folate-Targeted Photodynamic Therapy of Drug Resistant Cancers.
Karges J; Tharaud M; Gasser G
J Med Chem; 2021 Apr; 64(8):4612-4622. PubMed ID: 33818111
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
